- ECHA
- Information on Chemicals
- Adopted opinions and previous consultations on applications for authorisation
Adopted opinions and previous consultations on applications for authorisation
Adopted opinions and previous consultations on applications for authorisation
Adopted opinions and previous consultations on applications for authorisation
This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.
On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid.
Related links
0234-02 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | Maschinenfabrik Kaspar Walter GmbH & Co KG | Chromium trioxide-based functional chrome plating of cylinders used in the rotogravure printing and embossing industry. | Opinions adopted | |
0234-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | Maschinenfabrik Kaspar Walter GmbH & Co KG | Formulation of chromium trioxide-based electrolyte for electroplating process. | Opinions adopted | |
0233-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | Betz-Chrom GmbH | Chromium trioxide-based functional chrome plating of components with diverse geometries and dimensions, requiring specialized equipment and process knowledge, for applications in demanding industry sectors such as mechanical engineering, metalworking and processing, aerospace, automotive, and medical technology. | Opinions adopted | |
0232-01 | Initial | Dichromium tris(chromate) | 246-356-2 | 24613-89-6 | Monroe Czechia s.r.o. | Use of dichromium tris(chromate) in a post-treatment step of the autodeposition coating process of shock absorbers for automotive vehicles. | Opinions adopted | |
0231-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | Kesseboehmer Beschlagsysteme GmbH&Co.KG | Use of chromium trioxide for decorative/functional application in the furniture, sanitary and automotive sector. | Opinions adopted | |
0230-01 | Initial | 4-Nonylphenol, branched and linear, ethoxylated | - | - | Safran Landing Systems; SOCIETE DE TRAITEMENTS ELECTROLYTIQUES NORMALISES S.T.E.N. | Industrial use of 4-NPnEO as non-reactive surfactant in the sealing product in sulfuric acid anodization process of aluminium alloy parts of aircraft landing gears | Withdrawn | |
0229-01 | Review report | Chromium trioxide | 215-607-8 | 1333-82-0 | Volta Energy Solutions Hungary Kft | Industrial formulation of a chromium trioxide solution below 0.1% w/w concentration for the passivation of copper foil used in the manufacture of Lithium Ion Batteries (LiB) for motorised vehicles | Opinions adopted | |
0228-01 | Initial | Chromium trioxide | 215-607-8 | 1333-82-0 | Eaton S.R.L; Eaton Automotive Systems sp.zoo | The use of Chromium Trioxide (EC 215-607-8) by Eaton Vehicle Group (Eaton) across two legal entities in the functional chrome plating of engine valves and valve actuation (“lash adjusters”) | Opinions adopted | |
0227-01 | Review report | Trichloroethylene | 201-167-4 | 79-01-6 | ROQUETTE Frères | Use as a processing aid in the biotransformation of starch to obtain betacyclodextrin | Opinions adopted | |
0226-01 | Initial | 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated | - | - | LETI Pharma, S.L.U. [name of applicant in the original application: Laboratorios LETI, S.L.U. updated due to a notified change of corporate name] | Use of 4-tert-OPnEO in aqueous buffers during the manufacturing process of the active pharmaceutical ingredient (Protein Q) of the veterinary vaccine LetiFend® | Commission decided | |